Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of the Head and Neck are cancers that are known collectively as head and neck cancers. Usually, they start in the squamous cells that line the mucosal surfaces of the head and neck (for example, those inside the mouth, throat, and voice box). Oral cavity and larynx cancers are generally associated with tobacco consumption, alcohol abuse or both, whereas pharynx cancers are increasingly attributed to infection with human papillomavirus (HPV), primarily HPV-16.

Showing 1–12 of 18 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
Filters Sort results
Product
Antigen
Molecular Class
Drug Brand
Product Concentration
Volume per Vial
Quantity per vial
Storage Temperature
Expiry Date
Price
EGFR
Monoclonal Antibody
Erbitux®
5 mg/mL
400 µL
2 mg
-80°C
11/2019
224,00 
view product
Max: 10
Min: 1
Step: 1
EGFR
Monoclonal Antibody
Erbitux®
5 mg/mL
400 µL
2 mg
-80°C
01/2020
224,00 
view product
Max: 10
Min: 1
Step: 1
EGFR
Monoclonal Antibody
Erbitux®
5 mg/mL
400 µL
2 mg
-80°C
05/2021
224,00 
view product
Max: 10
Min: 1
Step: 1
EGFR
Monoclonal Antibody
Erbitux®
5 mg/mL
1000 µL
5 mg
-80°C
09/2021
561,00 
view product
Max: 10
Min: 1
Step: 1
EGFR
Monoclonal Antibody
Erbitux®
5 mg/mL
400 µL
2 mg
2-8°C / -80°C
11/2021
224,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
08/2018
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
10/2018
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
02/2018
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
05/2019
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
01/2019
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
09/2020
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
11/2020
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
200 µL
2 mg
-80°C
02/2021
269,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
80 µL
2 mg
-80°C
07/2018
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
80 µL
2 mg
-80°C
12/2018
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
80 µL
2 mg
-80°C
03/2019
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
80 µL
2 mg
-80°C
07/2019
794,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
80 µL
2 mg
2-8°C / -80°C
04/2022
794,00 
view product
Max: 10
Min: 1
Step: 1

Not looking for Squamous Cell Carcinoma of Head and Neck?

Search our therapeutic molecules product database

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.